Pfizer reported a third-quarter loss during Tuesday’s earnings call as the demand for its COVID-19 vaccines and one popular antiviral medication to treat the virus decreased substantially, according to CNBC. The pharmaceutical giant announced it recorded a write-off of $5.6 billion due to the drug Paxlovid and its vaccine, Comirnaty. Paxlovid lost the company $4.7 […]
Source: Pfizer Reports Massive Loss as Covid Vaccines and Paxlovid Doses Are Returned